MiR-34a Chemosensitizes Bladder Cancer Cells to Cisplatin Treatment Regardless of P53-Rb Pathway Status

International Journal of Cancer - United States
doi 10.1002/ijc.26256
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley